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Biofilms – adherent bacterial communities embed-
ded in a polymer matrix – are common in nature and
can cause persistent human infections that are
highly resistant to antibiotics. Recent work provides
insight into how these communities develop and
function, and offers clues to combating them.
Microorganisms in natural environments, faced with
physical, chemical and biological threats, often find
themselves up against a wall, both literally and figura-
tively. Their response? Grab that wall and hold on!
Adherence to surfaces can lead to the development of
‘biofilms’: durable microbial communities embedded
in polysaccharide matrices [1]. Biofilms are being
increasingly scrutinized at the cellular and molecular
level, partly in recognition of their relevance to human
disease. Pathogenic microbes that create biofilms can
cause persistent infections that defy the immune
system and resist elimination by antibiotics [2]. Recent
work is revealing programs of gene expression in
biofilms that may provide ideas for new therapeutic
approaches to deal with this challenge.
Biofilm development begins when ‘planktonic’
bacteria — unattached individual cells — adhere to a
surface (Figure 1) [1]. Diverse sites can be colonized,
including mineral surfaces, living and dead plant or
animal tissues, and synthetic polymers, ceramics and
metal alloys. Adherence mechanisms vary depending
on the microbe and surface. As adherent cells grow
and divide, proximity to the surface induces physio-
logical adaptations, including secretion of exopolysac-
charides (EPSs) to create a protective matrix
surrounding the cells [3]. Hydrated EPS contributes
the bulk of the volume of a biofilm, and is primarily
responsible for its slimy macroscopic properties. Fully
developed biofilms are surprisingly elaborate struc-
tures, with pillars rising up from mats of jumbled cells,
permeated by fluid-filled microchannels [1]. These
dynamic communities can spread across surfaces,
incorporate particulates and other microbes from the
surrounding environment, and continually shed new
planktonic cells.
Bacterial biofilms that form in the human body can
have dire consequences [2]. Acid-producing strepto-
cocci in dental plaque are responsible for cavity for-
mation in teeth, and some plaque inhabitants are
associated with periodontal disease. Certain oral
streptococci can, if provided access to the blood-
stream, colonize cardiac tissue or valves, causing
potentially fatal endocarditis. Biofilms are especially
problematic on in-dwelling medical devices, including
artificial heart valves, pacemakers, synthetic joints and
catheters. Biofilms are foci for persistent inflammation,
resulting in collateral damage to adjacent tissues in
addition to any direct damage by the pathogen. The
EPS matrix shields most of the bacteria from effective
opsonization and phagocytosis, making them very dif-
ficult to dislodge. Antibiotic treatment is frequently
unsuccessful in resolving biofilm-based infections, so
surgical removal of infected tissue or replacement of
a colonized device may be necessary.
Eradication of pathogenic biofilms would be facili-
tated by better understanding of their development
and metabolism. Studies of gene expression, and the
identification of gene products necessary for biofilm
formation or resistance to antimicrobials, should be a
significant help. Work has probably advanced farthest
with the bacterium Pseudomonas aeruginosa, a noto-
rious opportunistic pathogen that infects burns and
wounds, colonizes some types of indwelling devices
and causes chronic lung infections in most cystic
fibrosis (CF) sufferers. The gradual but inevitable pul-
monary deterioration, and eventual lethality, resulting
from such infections in CF patients make this a com-
pelling area of study. Thick airway mucus in CF patients
impairs mucocillary clearance of bacteria, and ele-
vated salt concentrations impair bacteriocidal pep-
tides in mucus [4]. Once P. aeruginosa cells gain a
foothold, they begin to produce the EPS alginate,
along with proteases and exotoxins that destroy lung
tissue and progressively diminish respiratory capacity.
How do Pseudomonas cells know when they are in
conditions appropriate for forming a biofilm? Many
environmental features are probably sensed, but ‘self-
awareness’ of the bacterial population is clearly a key
element. Bacteria sense cell density by ‘quorum
sensing’ [5], which relies on production of acylho-
moserine lactone (AHL) signal molecules which freely
diffuse across cell membranes. At high densities of
AHL-producing cells, elevated AHL concentrations
signal a transcriptional activator to turn on genes 
that are advantageous under crowded conditions.
P. aeruginosa has two quorum-sensing systems, las
and rhl, which use different AHLs and transcription
factors — LasR and RhlR — to control distinct sets of
genes involved in pathogenesis [6].
Strains with mutations of the las or rhl quorum-
sensing systems show attenuated virulence in experi-
mental animal infections [7], suggesting inhibition of
quorum sensing as a potential therapeutic strategy for
treating P. aeruginosa infections [8]. Is reduced viru-
lence at least partly due to effects on biofilm forma-
tion? las mutants are indeed defective in biofilm
formation under laboratory conditions; the importance
of rhl is less clear [8,9]. To examine this further, De
Kievet et al. [9] looked at expression of las and rhl-
dependent genes during biofilm development. Reporter
genes for each system were expressed primarily in
densely packed cells very close to the substrate to
which the biofilm was attached. Expression was rare
in cells distant from the substrate, presumably
because the AHL signal is lost by diffusion to the over-
lying fluid. The las system was active in nearly 50% of
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the cells in four day old biofilms, but declined to less
than 10% of the cells by eight days. In contrast, the rhl
system was active in ~15% of the cells at four days,
but maintained a steadier level (~10%) through 6–8
days. Both systems are active in sputum samples
from infected CF patients, suggesting that quorum
sensing occurs in the lung environment [10]. The rhl
AHL is generally more abundant than the las AHL in
sputum samples; regulation of these systems in host
environments merits further study [10].
The most extensive examination of P. aeruginosa
gene expression in biofilms to date has been pre-
sented by Whitely et al. [11]. To compare gene expres-
sion between planktonic and biofilm cells, they
examined bacteria grown in a chemostat, either free
swimming or adhering to granite pebbles. mRNA
levels were compared using microarrays with coding
sequences from 5500 genes identified in the P. aerug-
inosa genomic DNA sequence [12]. Surprisingly, only
73 genes, 1.3% of the total, showed significantly dif-
ferent expression levels in the biofilm (defined as a
more than two-fold increase or decrease relative to
the planktonic control). The planktonic control culture
was sufficiently dense to activate quorum-dependent
genes, so these were not among the differentially
expressed population (E.P. Greenberg, personal com-
munication). While these results almost certainly
underestimate the number of genes whose expression
changes in pathogenic biofilms, where additional
stimuli come into play, they still provide a basic cast
of characters relevant to biofilm production.
Flagellar motility and adhesion via pili are important
for initiating biofilm formation in P. aeruginosa [13],
but genes involved in building flagella and pili are
repressed as the biofilm grows [11]. Previous work
showed that repression of flagellar genes is depen-
dent on AlgT, which is also necessary for induction of
enzymes for alginate synthesis [14]. AlgT is one of
several sigma (promoter specificity) subunits of RNA
polymerase in P. aeruginosa. Mutational inactivation
of MucA, an antagonist of AlgT, is usually responsible
for the mucoid phenotype (resulting from hyperpro-
duction of alginate) frequently observed in P. aerugi-
nosa isolated from CF patients [15]. Two other sigma
subunits showed altered expression levels in biofilms:
RpoH expression increased, while RpoS expression
declined [11]. RpoH controls heat shock response
genes in bacteria, while RpoS usually regulates sta-
tionary phase gene expression, as well as response 
to stresses such as osmotic, temperature and pH
shifts. An rpoS– mutant was found to resemble
mucoid strains in forming biofilms which were thicker
than wild-type and more resistant to the antibiotic
tobramycin, an aminoglycoside antibiotic important in
the treatment of P. aeruginosa lung infections [11].
How RpoS suppresses biofilm functions, and is itself
regulated, are as yet unknown.
EPS production is an obvious target for the devel-
opment of anti-biofilm therapeutics, as elimination of
the matrix might allow available antibiotics to kill the
responsible bacteria. Expression of enzymes for algi-
nate synthesis is dramatically increased in laboratory
biofilms, relative to planktonic cells, when a mucoid P.
aeruginosa strain is used [16]. Whitely et al. [11] did
not observe elevated expression of alginate biosyn-
thetic enzymes in their biofilms, because the P. aerug-
inosa lab strain they used (strain PAO1) produces only
trace amounts of alginate, preferring to use other
polysaccharides in the matrix. Microarray analysis will
be applied to alginate-producing strains in the future
to help understand the complex regulation of this
process [15,16]. Understanding strain-specific varia-
tions in EPS and biofilm production is also important,
as these properties are subject to strong selection in
the host environment [15]. Conversely, these proper-
ties can be subject to negative selection in the lab: it
was recently reported that environmental isolates of
Bacillus subtilis form complex films containing aerial
fruiting bodies filled with spores, never observed in
decades of laboratory experimentation on endospore
formation in this species [17]. Presumably because
B. subtilis strain propagation and sporulation experi-
ments were done in shaken broth cultures where
biofilms do not form, mutations accumulated to the
point that this ability was lost.
There is evidence that the physical and chemical
properties of the negatively charged EPS matrix alone
do not fully explain the extraordinary ability of biofilms
to survive antibiotic treatment [18]. As even planktonic
P. aeruginosa cells are intrinsically resistant to many
antimicrobials, do the microarray results shed light on
other mechanisms by which survival is enhanced?
Curiously, none of the many efflux pumps suspected
to contribute to antibiotic resistance in P. aeruginosa
[12] was induced in the experimental biofilm [11].
Reduced membrane permeability is, however, known
to contribute to resistance to antibiotics in various
microbes. The tolA gene product affects lipopolysac-
charide (LPS) structure in the outer membrane of
Gram-negative bacteria, and underproduction of TolA
Figure 1. Biofilm development.
Flagella are shown in red, pili in orange,
and the extracellular polysaccharide
matrix in yellow. This diagram refers
specifically to Pseudomonas aeruginosa,
but the general stages of biofilm develop-
ment — initial adhesion, proliferation,
induction of biofilm gene expression,
secretion of extracellular polymers to
create a matrix — are probably similar in
all bacteria.
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results in hypersensitivity to aminoglycoside antibi-
otics [11]. Expression of tolA increased roughly four-
fold in the P. aeruginosa biofilm, perhaps inducing
changes in membrane composition that affect antibi-
otic entry. Electron transport and transmembrane
electrical potential also affect aminoglycoside perme-
ability; the observed three-fold repression of cyto-
chrome c oxidase in the biofilm could thereby also
impact the influx of such drugs. It should be pointed
out that the functions of a third of the biofilm-regu-
lated genes (25 out of 73) are unknown; some of these
genes could be relevant to resistance to antimicro-
bials. Expression of a subset of the genes of unknown
function was further altered in response to tobramycin
treatment, providing incentive to examine their possi-
ble roles in drug resistance.
A fuller picture of P. aeruginosa gene regulation in
biofilms will emerge as biofilms are examined during
their development, under different environmental con-
ditions and on different surfaces. It is hoped that gene
expression can be directly examined in bacteria in
sputum and other clinical samples, to maximize rele-
vance to pathogenesis (E.P. Greenberg, personal com-
munication). The genetics of biofilm formation in other
pathogens is not being ignored either, judging from
contributions to a recent volume devoted to this subject
[19]. The availability of genomic DNA sequences for
several biofilm-forming pathogens means we will be
seeing more microarray studies in the near future.
Vibrio cholerae, the agent of cholera, a severe diarrheal
disease of humans, will probably be first in line. There
is intriguing evidence that biofilm formation on marine
detritus or copepod shells facilitates the survival of V.
cholerae between epidemics. ‘Rugose’ variants of V.
cholerae isolated from infected individuals generate
profuse EPS and thick biofilms in the lab [20], analo-
gous to mucoid strains of P. aeruginosa. Microarray
analysis of gene expression in biofilms by rugose vari-
ants of V. cholerae is underway by Fitnat Yildiz and
Gary Schoolnik of Stanford University. The results of
these and other ongoing studies should make for fasci-
nating comparisons with the Pseudomonas data, and
will hopefully contribute to reducing the threat posed by
pathogenic biofilms to human health.
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